3 results match your criteria: "and Ochsner Medical Center-Kenner Hospital[Affiliation]"
Recent advances in the management of gastroenteropancreatic neuroendocrine tumors: Discussion.
Clin Adv Hematol Oncol
April 2017
LSU Health Sciences Center School of Medicine, New Orleans, Louisiana, and Ochsner Medical Center-Kenner Hospital, Kenner, Louisiana.
Surgical approaches for patients with gastroenteropancreatic nuroendocrine tumors.
Clin Adv Hematol Oncol
April 2017
LSU Health Sciences Center School of Medicine, New Orleans, Louisiana, and Ochsner Medical Center-Kenner Hospital, Kenner, Louisiana.
Recent advances in the management of gastroenteropancreatic neuroendocrine tumors: insights from the 2017 ASCO Gastrointestinal Cancers Symposium.
Clin Adv Hematol Oncol
April 2017
LSU Health Sciences Center School of Medicine, New Orleans, Louisiana, and Ochsner Medical Center-Kenner Hospital, Kenner, Louisiana.
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare malignancies that originate in the gastrointestinal system. GEP-NETs are typically indolent, but tumors known as "functional" secrete hormones that can lead to a complex of symptoms, including flushing, diarrhea, bronchospasm, and valvular heart disease. Management of patients with GEP-NETs requires a multidisciplinary approach, as treatment modalities include surgery, radiology, and pharmacotherapy.
View Article and Find Full Text PDF